Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-7 ERVK-21 ERVK-9 PGC ERVK-18 ERVK-24	4.56e-07	37	160	6	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-7 ERVK-21 ERVK-9 PGC ERVK-18 ERVK-24	5.38e-07	38	160	6	GO:0070001
GeneOntologyMolecularFunction	endopeptidase activity	ATG4A MBTPS1 MMP28 PRSS55 ERVK-7 ERVK-21 ERVK-9 OVCH1 PGC MMP25 PHEX ERVK-18 MMP1 ERVK-24	9.88e-06	430	160	14	GO:0004175
GeneOntologyMolecularFunction	peptidase activity	ATG4A MBTPS1 UFSP2 MMP28 VASH1 PRSS55 ERVK-7 ERVK-21 DPP3 ERVK-9 OVCH1 PGC MMP25 PHEX ERVK-18 MMP1 ERVK-24	2.06e-05	654	160	17	GO:0008233
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	HLA-E HLA-F CLEC2D	3.16e-04	17	160	3	GO:0046703
GeneOntologyCellularComponent	MHC protein complex	HLA-DOB HLA-DPB1 HLA-E HLA-F	4.44e-05	26	161	4	GO:0042611
GeneOntologyCellularComponent	extracellular matrix	FRAS1 MXRA5 CD248 MMP28 LAMB1 NYX TECTA MMP25 SNED1 MFAP5 PRELP KAZALD1 MMP1 NPNT HDGF	1.73e-04	656	161	15	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	FRAS1 MXRA5 CD248 MMP28 LAMB1 NYX TECTA MMP25 SNED1 MFAP5 PRELP KAZALD1 MMP1 NPNT HDGF	1.79e-04	658	161	15	GO:0030312
MousePheno	abnormal immune serum protein physiology	SMG1 MBTPS1 APOBEC3D MMP28 ARHGEF5 HLA-E HLA-F PELI2 ARHGAP17 DPP3 PGAM5 BTN2A1 ARID5A MMP25 PHEX TNFRSF13B PKN1 IL1RL1 SLFN11 UNC93B1 PRKDC MMP1 SLC6A14 CD276	1.84e-05	1165	114	24	MP:0002723
Domain	EGF	TPO FRAS1 CD248 LAMB1 TECTA SNED1 NELL2 FAT2 TENM1 LRP2 NPNT	4.37e-06	235	155	11	SM00181
Domain	IGc1	HLA-DOB HLA-DPB1 HLA-E HLA-F IGHA2 CD276	6.84e-06	56	155	6	SM00407
Domain	EGF-like_dom	TPO FRAS1 CD248 LAMB1 TECTA SNED1 NELL2 FAT2 TENM1 LRP2 NPNT	7.58e-06	249	155	11	IPR000742
Domain	Ig_C1-set	HLA-DOB HLA-DPB1 HLA-E HLA-F IGHA2 CD276	8.41e-06	58	155	6	IPR003597
Domain	Calx_beta	FRAS1 ADGRV1 SLC8A2	3.05e-05	8	155	3	SM00237
Domain	Calx_beta	FRAS1 ADGRV1 SLC8A2	4.54e-05	9	155	3	IPR003644
Domain	Calx-beta	FRAS1 ADGRV1 SLC8A2	4.54e-05	9	155	3	PF03160
Domain	Growth_fac_rcpt_	FRAS1 CD248 LAMB1 NELL2 EGFR LRP2 KAZALD1 NPNT	4.82e-05	156	155	8	IPR009030
Domain	IG_LIKE	MXRA5 MYLK HLA-DOB HLA-DPB1 HLA-E HLA-F BTN2A1 IGHA2 CD101 KAZALD1 IL1RL1 MPZL2 IGSF3 CD276	6.15e-05	491	155	14	PS50835
Domain	EGF_CA	TPO CD248 SNED1 NELL2 FAT2 LRP2 NPNT	7.14e-05	122	155	7	SM00179
Domain	EGF-like_Ca-bd_dom	TPO CD248 SNED1 NELL2 FAT2 LRP2 NPNT	7.91e-05	124	155	7	IPR001881
Domain	Ig-like_dom	MXRA5 MYLK HLA-DOB HLA-DPB1 HLA-E HLA-F BTN2A1 IGHA2 CD101 KAZALD1 IL1RL1 MPZL2 IGSF3 CD276	7.95e-05	503	155	14	IPR007110
Domain	C1-set	HLA-DOB HLA-DPB1 HLA-E HLA-F IGHA2	8.41e-05	54	155	5	PF07654
Domain	Ig/MHC_CS	HLA-DOB HLA-DPB1 HLA-E HLA-F IGHA2	1.19e-04	58	155	5	IPR003006
Domain	IG_MHC	HLA-DOB HLA-DPB1 HLA-E HLA-F IGHA2	1.40e-04	60	155	5	PS00290
Domain	EGF_Ca-bd_CS	TPO CD248 SNED1 NELL2 LRP2 NPNT	1.57e-04	97	155	6	IPR018097
Domain	EGF_CA	TPO CD248 SNED1 NELL2 LRP2 NPNT	1.76e-04	99	155	6	PS01187
Domain	DUF2075	SLFN5 SLFN11	2.04e-04	3	155	2	PF09848
Domain	DUF2075	SLFN5 SLFN11	2.04e-04	3	155	2	IPR018647
Domain	EGF-type_Asp/Asn_hydroxyl_site	TPO CD248 SNED1 NELL2 LRP2 NPNT	2.55e-04	106	155	6	IPR000152
Domain	MHC_I/II-like_Ag-recog	HLA-DOB HLA-DPB1 HLA-E HLA-F	2.70e-04	38	155	4	IPR011162
Domain	EGF_1	TPO CD248 LAMB1 SNED1 NELL2 FAT2 TENM1 LRP2 NPNT	2.85e-04	255	155	9	PS00022
Domain	EGF-like_CS	TPO CD248 LAMB1 SNED1 NELL2 FAT2 TENM1 LRP2 NPNT	3.38e-04	261	155	9	IPR013032
Domain	EGF_2	TPO CD248 LAMB1 SNED1 NELL2 FAT2 TENM1 LRP2 NPNT	3.77e-04	265	155	9	PS01186
Domain	IGv	BTN2A1 CD101 MPZL2 IGSF3 CD276	3.99e-04	75	155	5	SM00406
Domain	Pept_M10A_stromelysin-type	MMP28 MMP25 MMP1	4.17e-04	18	155	3	IPR016293
Domain	VWC_out	FRAS1 TECTA NELL2	4.93e-04	19	155	3	SM00215
Domain	6-blade_b-propeller_TolB-like	TENM1 LRP2 EIF3B LRP5L	5.68e-04	46	155	4	IPR011042
Domain	PG_binding_1	MMP28 MMP25 MMP1	5.76e-04	20	155	3	PF01471
Domain	Peptidoglycan-bd-like	MMP28 MMP25 MMP1	5.76e-04	20	155	3	IPR002477
Domain	NIDO_dom	TECTA SNED1	6.73e-04	5	155	2	IPR003886
Domain	NIDO	TECTA SNED1	6.73e-04	5	155	2	SM00539
Domain	NIDO	TECTA SNED1	6.73e-04	5	155	2	PF06119
Domain	NIDO	TECTA SNED1	6.73e-04	5	155	2	PS51220
Domain	FATC	SMG1 PRKDC	6.73e-04	5	155	2	PF02260
Domain	EGF_CA	TPO CD248 NELL2 LRP2 NPNT	7.48e-04	86	155	5	PF07645
Domain	EGF_3	TPO CD248 SNED1 NELL2 FAT2 TENM1 LRP2 NPNT	7.86e-04	235	155	8	PS50026
Domain	Ig-like_fold	MXRA5 MYLK HLA-DOB HLA-DPB1 HLA-E HLA-F BTN2A1 SNED1 IGHA2 CD101 KAZALD1 IL1RL1 MPZL2 IGSF3 CD276	8.03e-04	706	155	15	IPR013783
Domain	Hemopexin-like_dom	MMP28 MMP25 MMP1	8.79e-04	23	155	3	IPR000585
Domain	Hemopexin-like_repeat	MMP28 MMP25 MMP1	8.79e-04	23	155	3	IPR018487
Domain	HEMOPEXIN	MMP28 MMP25 MMP1	8.79e-04	23	155	3	PS00024
Domain	-	MMP28 MMP25 MMP1	8.79e-04	23	155	3	2.110.10.10
Domain	HEMOPEXIN_2	MMP28 MMP25 MMP1	8.79e-04	23	155	3	PS51642
Domain	HX	MMP28 MMP25 MMP1	8.79e-04	23	155	3	SM00120
Domain	M10A_MMP	MMP28 MMP25 MMP1	8.79e-04	23	155	3	IPR033739
Domain	Hemopexin	MMP28 MMP25 MMP1	8.79e-04	23	155	3	PF00045
Domain	Pept_M10A	MMP28 MMP25 MMP1	8.79e-04	23	155	3	IPR021190
Domain	Peptidase_M10	MMP28 MMP25 MMP1	9.98e-04	24	155	3	PF00413
Domain	MHC_I_a_C	HLA-E HLA-F	1.00e-03	6	155	2	IPR010579
Domain	FAT	SMG1 PRKDC	1.00e-03	6	155	2	PS51189
Domain	FATC	SMG1 PRKDC	1.00e-03	6	155	2	PS51190
Domain	MHC_I_C	HLA-E HLA-F	1.00e-03	6	155	2	PF06623
Domain	FATC_dom	SMG1 PRKDC	1.00e-03	6	155	2	IPR003152
Domain	PIK_FAT	SMG1 PRKDC	1.00e-03	6	155	2	IPR014009
Domain	FATC	SMG1 PRKDC	1.00e-03	6	155	2	SM01343
Domain	-	MXRA5 MYLK HLA-DOB HLA-DPB1 HLA-E HLA-F BTN2A1 SNED1 CD101 KAZALD1 IL1RL1 MPZL2 IGSF3 CD276	1.27e-03	663	155	14	2.60.40.10
Domain	AlbA_2	SLFN5 SLFN11	1.40e-03	7	155	2	PF04326
Domain	Schlafen	SLFN5 SLFN11	1.40e-03	7	155	2	IPR029684
Domain	Schlafen_AAA_dom	SLFN5 SLFN11	1.40e-03	7	155	2	IPR007421
Domain	Retrov_capsid_C	ZNF274 ZNF213 ZSCAN32 ERVK-5	1.46e-03	59	155	4	IPR008916
Domain	ASX_HYDROXYL	TPO SNED1 NELL2 LRP2 NPNT	1.47e-03	100	155	5	PS00010
Domain	Peptidase_Metallo	MMP28 MMP25 MMP1	1.75e-03	29	155	3	IPR006026
Domain	ZnMc	MMP28 MMP25 MMP1	1.75e-03	29	155	3	SM00235
Domain	MHC_II_b_N	HLA-DOB HLA-DPB1	1.85e-03	8	155	2	PD000328
Domain	MHC_II_b_N	HLA-DOB HLA-DPB1	2.37e-03	9	155	2	IPR000353
Domain	MHC_II_beta	HLA-DOB HLA-DPB1	2.37e-03	9	155	2	SM00921
Domain	MHC_II_beta	HLA-DOB HLA-DPB1	2.37e-03	9	155	2	PF00969
Domain	ConA-like_dom	ADGRV1 BTN2A1 NELL2 FAT2 HNRNPUL2 NPNT TRIM60	2.38e-03	219	155	7	IPR013320
Domain	-	ARHGEF19 PLEKHG4 ARHGEF5 ALS2CL	2.88e-03	71	155	4	1.20.900.10
Domain	DH-domain	ARHGEF19 PLEKHG4 ARHGEF5 ALS2CL	2.88e-03	71	155	4	IPR000219
Domain	VWFC_2	FRAS1 TECTA NELL2	3.82e-03	38	155	3	PS50184
Domain	VWC	FRAS1 TECTA NELL2	3.82e-03	38	155	3	SM00214
Domain	EGF	CD248 TECTA SNED1 FAT2 LRP2	4.03e-03	126	155	5	PF00008
Domain	-	TENM1 LRP2 LRP5L	4.12e-03	39	155	3	2.120.10.30
Domain	-	MMP28 MMP25 PHEX MMP1	4.63e-03	81	155	4	3.40.390.10
Domain	MetalloPept_cat_dom	MMP28 MMP25 PHEX MMP1	4.63e-03	81	155	4	IPR024079
Domain	CYSTEINE_SWITCH	MMP28 MMP25 MMP1	4.74e-03	41	155	3	PS00546
Domain	ABC_transporter_CS	ABCC3 ABCA1 ABCB8	5.08e-03	42	155	3	IPR017871
Domain	VWF_dom	FRAS1 TECTA NELL2	5.08e-03	42	155	3	IPR001007
Domain	Pept_M10_metallopeptidase	MMP28 MMP25 MMP1	5.43e-03	43	155	3	IPR001818
Domain	MHC_II_a/b_N	HLA-DOB HLA-DPB1	5.83e-03	14	155	2	IPR014745
Domain	TIL_dom	TECTA LRP2	5.83e-03	14	155	2	IPR002919
Domain	-	HLA-DOB HLA-DPB1	5.83e-03	14	155	2	3.10.320.10
Domain	Ldl_recept_b	LRP2 LRP5L	5.83e-03	14	155	2	PF00058
Domain	LDLRB	LRP2 LRP5L	5.83e-03	14	155	2	PS51120
Domain	PI3/4_kinase_CS	SMG1 PRKDC	6.69e-03	15	155	2	IPR018936
Domain	LY	LRP2 LRP5L	6.69e-03	15	155	2	SM00135
Domain	LDLR_classB_rpt	LRP2 LRP5L	6.69e-03	15	155	2	IPR000033
Domain	AAA	ABCC3 ABCA1 ATAD5 CLPB ABCB8	7.05e-03	144	155	5	SM00382
Domain	AAA+_ATPase	ABCC3 ABCA1 ATAD5 CLPB ABCB8	7.05e-03	144	155	5	IPR003593
Domain	ABC_tran	ABCC3 ABCA1 ABCB8	7.38e-03	48	155	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCC3 ABCA1 ABCB8	7.38e-03	48	155	3	PS50893
Domain	-	SMG1 PRKDC	7.61e-03	16	155	2	1.10.1070.11
Domain	PI3Kc	SMG1 PRKDC	7.61e-03	16	155	2	SM00146
Domain	ABC_TRANSPORTER_1	ABCC3 ABCA1 ABCB8	7.81e-03	49	155	3	PS00211
Domain	ABC_transporter-like	ABCC3 ABCA1 ABCB8	8.26e-03	50	155	3	IPR003439
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ABCC3 CACNA2D1 MBTPS1 FRAS1 HLA-E HLA-F LPCAT4 LAMB1 DDX55 BTN2A1 NELL2 DNAJC10 EGFR HNRNPUL2 DHCR7 TNKS1BP1 TIMELESS UNC93B1 PCDH7 MFSD5 MSLN IGSF3 CD276	9.92e-09	1201	162	23	35696571
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-7 ERVK-21 ERVK-18	9.85e-07	5	162	3	12629516
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-21 ERVK-9 ERVK-18 ERVK-24	1.32e-06	18	162	4	18664271
Pubmed	HIV-1 gp120 modulates the immunological function and expression of accessory and co-stimulatory molecules of monocyte-derived dendritic cells.	HLA-DOB HLA-DPB1 HLA-E HLA-F	2.07e-06	20	162	4	12427289
Pubmed	Nef performance in macrophages: the master orchestrator of viral persistence and spread.	HLA-DOB HLA-DPB1 HLA-E HLA-F	2.07e-06	20	162	4	22103834
Pubmed	HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41.	HLA-DOB HLA-DPB1 HLA-E HLA-F	2.55e-06	21	162	4	8084338
Pubmed	Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy?	HLA-DOB HLA-DPB1 HLA-E HLA-F RNF216	2.70e-06	47	162	5	19149577
Pubmed	Role of HIV-1 Nef protein for virus replication in vitro.	HLA-DOB HLA-DPB1 HLA-E HLA-F	3.75e-06	23	162	4	19770068
Pubmed	Editorial. Nef: a notorious enigmatic factor in HIV biology.	HLA-DOB HLA-DPB1 HLA-E HLA-F	4.48e-06	24	162	4	22175768
Pubmed	HIV accessory proteins and surviving the host cell.	HLA-DOB HLA-DPB1 HLA-E HLA-F	5.32e-06	25	162	4	16091223
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-7 ERVK-21 ERVK-9 ERVK-18 ERVK-5 ERVK-24	5.40e-06	94	162	6	21542922
Pubmed	A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor.	HLA-E HLA-F PRKDC	5.46e-06	8	162	3	15383569
Pubmed	[The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites"of the endocytosis pathway].	HLA-DOB HLA-DPB1 HLA-E HLA-F	7.32e-06	27	162	4	12836198
Pubmed	Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob.	HLA-DOB HLA-E HLA-F	8.16e-06	9	162	3	28813660
Pubmed	Polymorphism of the Apl (Neu-1) locus in the mouse.	HLA-E HLA-F PGC	8.16e-06	9	162	3	7141491
Pubmed	One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef.	HLA-DOB HLA-DPB1 HLA-E HLA-F	8.51e-06	28	162	4	22103833
Pubmed	HIV/SIV escape from immune surveillance: focus on Nef.	HLA-DOB HLA-DPB1 HLA-E HLA-F	9.84e-06	29	162	4	15078178
Pubmed	Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model.	HLA-E HLA-F PRKDC	1.16e-05	10	162	3	37712758
Pubmed	HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice.	HLA-E HLA-F PRKDC	1.16e-05	10	162	3	37877672
Pubmed	Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.	HLA-E HLA-F PRKDC	1.16e-05	10	162	3	23869841
Pubmed	Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti-PD-1 Immune Checkpoint Inhibitor Cancer Therapy.	HLA-E HLA-F PRKDC	1.16e-05	10	162	3	38426910
Pubmed	Gene organization and recombinational hotspots in the murine major histocompatibility complex.	HLA-DOB HLA-E HLA-F	1.16e-05	10	162	3	3754180
Pubmed	NLGN4X TCR transgenic T cells to treat gliomas.	HLA-E HLA-F PRKDC	1.16e-05	10	162	3	37715782
Pubmed	Genetic and molecular mapping of the Hmt region of mouse.	HLA-E HLA-F PGC	1.16e-05	10	162	3	2573520
Pubmed	Simultaneous evaluation of treatment efficacy and toxicity for bispecific T-cell engager therapeutics in a humanized mouse model.	HLA-E HLA-F PRKDC	1.16e-05	10	162	3	37219526
Pubmed	Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.	HLA-E HLA-F PRKDC	1.16e-05	10	162	3	37966111
Pubmed	Immunoregulatory effects of HIV-1 Nef protein.	HLA-DOB HLA-DPB1 HLA-E HLA-F	1.47e-05	32	162	4	19449444
Pubmed	Differential effect of ATP binding cassette transporter A1 R219K and cholesteryl ester transfer protein TaqIB genotypes on HDL-C levels in overweight/obese and non-obese Chinese subjects.	ABCA1 CETP	2.16e-05	2	162	2	21591583
Pubmed	HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation.	HLA-E HLA-F	2.16e-05	2	162	2	35181585
Pubmed	HLA-F complex without peptide binds to MHC class I protein in the open conformer form.	HLA-E HLA-F	2.16e-05	2	162	2	20483783
Pubmed	Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase.	EGFR PRKDC	2.16e-05	2	162	2	16000298
Pubmed	Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase.	EGFR PRKDC	2.16e-05	2	162	2	25210793
Pubmed	Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis.	ABCA1 CETP	2.16e-05	2	162	2	19131637
Pubmed	EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.	EGFR PRKDC	2.16e-05	2	162	2	21266349
Pubmed	A novel variant of human Grb7 is associated with invasive esophageal carcinoma.	GRB7 EGFR	2.16e-05	2	162	2	9710451
Pubmed	Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.	EGFR ALDH1A1	2.16e-05	2	162	2	23465277
Pubmed	Phosphate transport in osteoblasts from normal and X-linked hypophosphatemic mice.	LAMB1 PHEX	2.16e-05	2	162	2	8082056
Pubmed	Cholesteryl ester transfer protein and ATP-binding cassette transporter A1 genotype alter the atorvastatin and simvastatin efficacy: time for genotype-guided therapy?	ABCA1 CETP	2.16e-05	2	162	2	22584245
Pubmed	ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression.	EGFR MMP1	2.16e-05	2	162	2	21440529
Pubmed	The impact of common polymorphisms in CETP and ABCA1 genes with the risk of coronary artery disease in Saudi Arabians.	ABCA1 CETP	2.16e-05	2	162	2	26936456
Pubmed	Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer.	HLA-E HLA-F	2.16e-05	2	162	2	25862890
Pubmed	SP3-induced Timeless transcription contributes to cell growth of lung adenocarcinoma cells.	SP3 TIMELESS	2.16e-05	2	162	2	38354174
Pubmed	Mapping of the L-methylmalonyl-CoA mutase gene to mouse chromosome 17.	HLA-E HLA-F PGC	2.74e-05	13	162	3	1970332
Pubmed	The I region of the C57BL/10 mouse: characterization and physical linkage to H-2K of an SB beta-like class II pseudogene, psi A beta 3.	HLA-DOB HLA-E HLA-F	3.48e-05	14	162	3	3860873
Pubmed	Electrophoretic analysis of liver neuraminidase-1 variation in mice and additional evidence concerning the location of NEU-1.	HLA-E HLA-F PGC	3.48e-05	14	162	3	3745925
Pubmed	Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.	HLA-E HLA-F CLEC2D	4.33e-05	15	162	3	14990792
Pubmed	Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity.	HLA-E HLA-F PRKDC	4.33e-05	15	162	3	38413714
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMG1 RAN MYLK BIVM LPCAT4 DDX55 PGAM5 PHEX DNAJC10 SACS N4BP2 SLC27A1 TENM1 CES3 DLAT PRKDC ALDH1A1 POTEI SLC6A14	4.55e-05	1442	162	19	35575683
Pubmed	Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery.	ABCA1 CETP DHCR7	5.31e-05	16	162	3	17855807
Pubmed	Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING.	HLA-E HLA-F PRKDC	5.31e-05	16	162	3	32723479
Pubmed	Localization of a mouse heat shock Hsp70 gene within the H-2 complex.	HLA-DOB HLA-E HLA-F	6.43e-05	17	162	3	1978715
Pubmed	Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.	KIF21B HLA-E LAMB1	6.43e-05	17	162	3	19915572
Pubmed	The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides.	HLA-E HLA-F	6.45e-05	3	162	2	10430630
Pubmed	[Single nucleotide polymorphisms of genes associated with high density lipoprotein metabolism in Chinese population].	ABCA1 CETP	6.45e-05	3	162	2	15696473
Pubmed	Characterization of a new subfamily of class I genes in the H-2 complex of the mouse.	HLA-E HLA-F	6.45e-05	3	162	2	3378834
Pubmed	Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor-mediated radiation resistance.	EGFR PRKDC	6.45e-05	3	162	2	22923485
Pubmed	Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells.	HLA-E HLA-F	6.45e-05	3	162	2	28740236
Pubmed	Comparative genomic aspects of rat, mouse and human MHC class I gene regions.	HLA-E HLA-F	6.45e-05	3	162	2	11173841
Pubmed	Removal of Qa-2 antigen alters the Ped gene phenotype of preimplantation mouse embryos.	HLA-E HLA-F	6.45e-05	3	162	2	1327207
Pubmed	Fine map of a region homologous to the rat grc complex in the TL region of the mouse.	HLA-E HLA-F	6.45e-05	3	162	2	8428772
Pubmed	Is dyslipidemia sustained during remission of nephrotic syndrome genetically determined? Evaluation of genetic polymorphisms of proteins involved in lipoprotein metabolism in children and adolescents with nephrotic syndrome.	ABCA1 CETP	6.45e-05	3	162	2	19341173
Pubmed	Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK.	EGFR PRKDC	6.45e-05	3	162	2	18789131
Pubmed	CTL and sequence analyses of MHC class IB antigens Qa1(c) (H2-T23(r)) and Qa1(d) (H2-T23(f)).	HLA-E HLA-F	6.45e-05	3	162	2	10369933
Pubmed	Antigen-presenting cells for naive transgenic gamma delta T cells. Potent activation by activated alpha beta T cells.	HLA-E HLA-F	6.45e-05	3	162	2	7561093
Pubmed	Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing.	HLA-E HLA-F	6.45e-05	3	162	2	18028286
Pubmed	Molecular cloning of a second human stanniocalcin homologue (STC2).	CRY2 PHEX	6.45e-05	3	162	2	9753616
Pubmed	Organization and structure of the H-2M4-M8 class I genes in the mouse major histocompatibility complex.	HLA-E HLA-F	6.45e-05	3	162	2	8319975
Pubmed	Expression of nonclassical class I major histocompatibility genes defines a tripartite organization of the mouse vomeronasal system.	HLA-E HLA-F	6.45e-05	3	162	2	18322080
Pubmed	Analysis of litter size and weight in mice differing in Ped gene phenotype and the Q region of the H-2 complex.	HLA-E HLA-F	6.45e-05	3	162	2	1865393
Pubmed	Hyperconservation of the N-formyl peptide binding site of M3: evidence that M3 is an old eutherian molecule with conserved recognition of a pathogen-associated molecular pattern.	HLA-E HLA-F	6.45e-05	3	162	2	12847252
Pubmed	Linkage of the preimplantation-embryo-development (Ped) gene to the mouse major histocompatibility complex (MHC).	HLA-E HLA-F	6.45e-05	3	162	2	3593832
Pubmed	Duplicated gene pairs and alleles of class I genes in the Qa2 region of the murine major histocompatibility complex: a comparison.	HLA-E HLA-F	6.45e-05	3	162	2	3004940
Pubmed	Murine MHC class Ib gene, H2-M2, encodes a conserved surface-expressed glycoprotein.	HLA-E HLA-F	6.45e-05	3	162	2	15045471
Pubmed	HMT, encoded by H-2M3, is a neoclassical major histocompatibility class I antigen.	HLA-E HLA-F	6.45e-05	3	162	2	8464890
Pubmed	A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site.	HLA-E HLA-F	6.45e-05	3	162	2	8245452
Pubmed	ADAP2 in heart development: a candidate gene for the occurrence of cardiovascular malformations in NF1 microdeletion syndrome.	SUZ12 ADAP2	6.45e-05	3	162	2	24711647
Pubmed	Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.	ABCA1 CETP	6.45e-05	3	162	2	25110219
Pubmed	Phosphorylation of the cryptochrome 1 C-terminal tail regulates circadian period length.	CRY2 PRKDC	6.45e-05	3	162	2	24158435
Pubmed	Identification of two major histocompatibility complex class Ib genes, Q7 and Q9, as the Ped gene in the mouse.	HLA-E HLA-F	6.45e-05	3	162	2	10208972
Pubmed	BLyF, a novel cell-type- and stage-specific regulator of the B-lymphocyte gene mb-1.	HLA-E HLA-F	6.45e-05	3	162	2	1545794
Pubmed	Extension of the H-2 TLb molecular map. Isolation and characterization of T13, T14, and T15 from the C57BL/6 mouse.	HLA-E HLA-F	6.45e-05	3	162	2	2831142
Pubmed	Two "Qa" specificities: Qa-m7 and Qa-m8 defined by monoclonal antibodies.	HLA-E HLA-F	6.45e-05	3	162	2	6190932
Pubmed	Analysis of the Qa-4 allodeterminant.	HLA-E HLA-F	6.45e-05	3	162	2	2581893
Pubmed	Class Ib MHC-Mediated Immune Interactions Play a Critical Role in Maintaining Mucosal Homeostasis in the Mammalian Large Intestine.	HLA-E HLA-F	6.45e-05	3	162	2	34911745
Pubmed	Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776.	EGFR PRKDC	6.45e-05	3	162	2	22815474
Pubmed	[Geographical characteristics of single nucleotide polymorphism of candidate genes associated with coronary artery disease in Chinese Han population].	ABCA1 CETP	6.45e-05	3	162	2	19099922
Pubmed	Repression of the nonclassical MHC class I gene H2-M1 by cis-acting silencer DNA elements.	HLA-E HLA-F	6.45e-05	3	162	2	8753857
Pubmed	Combinatorial coexpression of neural and immune multigene families in mouse vomeronasal sensory neurons.	HLA-E HLA-F	6.45e-05	3	162	2	12620187
Pubmed	Expression in L cells of transfected class I genes from the mouse major histocompatibility complex.	HLA-E HLA-F	6.45e-05	3	162	2	2991930
Pubmed	Polymorphism within a TCRAV family influences the repertoire through class I/II restriction.	HLA-E HLA-F	6.45e-05	3	162	2	9570535
Pubmed	Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.	HLA-E HLA-F	6.45e-05	3	162	2	33020145
Pubmed	Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.	ABCA1 CETP	6.45e-05	3	162	2	23181436
Pubmed	Regulation of human CETP gene expression: role of SP1 and SP3 transcription factors at promoter sites -690, -629, and -37.	SP3 CETP	6.45e-05	3	162	2	12730302
Pubmed	Identification of the Ped gene at the molecular level: the Q9 MHC class I transgene converts the Ped slow to the Ped fast phenotype.	HLA-E HLA-F	6.45e-05	3	162	2	7819451
Pubmed	Novel mRNA species from a Q-subregion class-I gene of the murine major histocompatibility complex.	HLA-E HLA-F	6.45e-05	3	162	2	3443307
Pubmed	Reduced alpha-adrenoceptor responsiveness and enhanced baroreflex sensitivity in Cry-deficient mice lacking a biological clock.	CRY2 CNN1	6.45e-05	3	162	2	15860530
Pubmed	Qa-1-Restricted CD8+ T Cells Can Compensate for the Absence of Conventional T Cells during Viral Infection.	HLA-E HLA-F	6.45e-05	3	162	2	30970256
Pubmed	Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition.	HLA-E HLA-F	6.45e-05	3	162	2	12874228
Pubmed	HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes.	HLA-E HLA-F	6.45e-05	3	162	2	16570139
Pubmed	Role of the Ped gene and apoptosis genes in control of preimplantation development.	HLA-E HLA-F	6.45e-05	3	162	2	9604770
Interaction	FBXO2 interactions	CACNA2D1 FRAS1 LAMB1 ADGRV1 BTN2A1 CBLIF SNED1 NELL2 PPT2 EGFR PRELP CD101 LRP2 IGSF3 CD276	6.34e-07	411	154	15	int:FBXO2
Cytoband	6p22.3-p22.1	MRS2 SCGN	7.39e-05	4	162	2	6p22.3-p22.1
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	MMP28 MRM1 GRB7 SLFN5 SLFN11	1.95e-04	149	162	5	chr17q12
Cytoband	17q12	MRM1 GRB7 SLFN5 SLFN11	4.33e-04	99	162	4	17q12
GeneFamily	C1-set domain containing	HLA-DOB HLA-DPB1 HLA-E HLA-F	9.77e-05	42	104	4	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-DOB HLA-DPB1 HLA-E HLA-F	1.18e-04	44	104	4	588
GeneFamily	Endogenous ligands\|Matrix metallopeptidases	MMP28 MMP25 MMP1	3.43e-04	24	104	3	891
GeneFamily	Schlafen family	SLFN5 SLFN11	6.75e-04	7	104	2	1110
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MXRA5 MYLK CD101 KAZALD1 IL1RL1	2.38e-03	161	104	5	593
GeneFamily	Adenosine receptors\|V-set domain containing	BTN2A1 CD101 MPZL2 IGSF3 CD276	2.51e-03	163	104	5	590
Coexpression	NABA_CORE_MATRISOME	FRAS1 MXRA5 LAMB1 NYX TECTA SNED1 MFAP5 NELL2 PRELP VWA5B1 NPNT	8.43e-07	275	156	11	M5884
Coexpression	NABA_ECM_GLYCOPROTEINS	FRAS1 MXRA5 LAMB1 TECTA SNED1 MFAP5 NELL2 VWA5B1 NPNT	2.82e-06	196	156	9	M3008
Coexpression	NABA_CORE_MATRISOME	FRAS1 LAMB1 NYX TECTA SNED1 MFAP5 NELL2 PRELP VWA5B1 NPNT	5.34e-06	270	156	10	MM17057
Coexpression	DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS	ABCC3 APOBEC3D HLA-E HLA-F ARHGAP17 NRROS SP110 ARID5A CLEC2D PKN1 IL1RL1 SLFN11 UNC93B1 ADAP2	1.98e-05	615	156	14	MM3641
Coexpression	NABA_ECM_GLYCOPROTEINS	FRAS1 LAMB1 TECTA SNED1 MFAP5 NELL2 VWA5B1 NPNT	1.98e-05	191	156	8	MM17059
Coexpression	LEE_BMP2_TARGETS_UP	ABCA1 APOBEC3D HLA-E HLA-F GRB7 PELI2 CRY2 ACAD8 SCMH1 PRELP DCHS1 PKN1 UNC93B1 MPZL2 IGSF3 NPNT	2.62e-05	805	156	16	MM1067
Coexpression	NABA_MATRISOME	TPO FRAS1 MXRA5 MMP28 WNT8B LAMB1 NYX TECTA MMP25 SNED1 MFAP5 NELL2 PRELP CLEC2D KAZALD1 MMP1 VWA5B1 NPNT	4.17e-05	1026	156	18	M5889
Coexpression	LIU_PROSTATE_CANCER_DN	ABCC3 MYLK CD248 HLA-E LPCAT4 LAMB1 SLFN5 BTN2A1 NELL2 PRELP MPZL2 PCDH7	4.18e-05	493	156	12	M19391
Coexpression	YU_MYC_TARGETS_DN	ABCA1 HLA-DOB HLA-E HLA-F UNC93B1	5.40e-05	68	156	5	MM632
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_1000	FRAS1 PDE3A ABCA1 MYLK CYP2E1 CD248 HLA-F SLFN5 SP110 MFAP5 EGFR PRELP CLEC2D CES3 LRP2 KAZALD1 ALDH1A1 MPZL2 MSLN NPNT	1.04e-06	778	155	20	gudmap_kidney_adult_RenalCapsule_1000
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAN HLA-DOB HLA-DPB1 INPP5F SNED1 SACS IGHA2 CLEC2D TNFRSF13B EIF3B	1.97e-09	196	156	10	0175b097ad1338a07afebe3b5c7fd0bb0bb950f7
ToppCell	facs-BAT-Fat-18m-Mesenchymal\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 CD248 LAMB1 MFAP5 EGFR PRELP ALDH1A1 PCDH7 IGSF3	2.36e-08	189	156	9	bba28f57a0708515fdd5acd9592dbbe4a4f57116
ToppCell	facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 CD248 LAMB1 MFAP5 EGFR PRELP ALDH1A1 PCDH7 IGSF3	2.36e-08	189	156	9	cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2
ToppCell	facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 CD248 LAMB1 MFAP5 EGFR PRELP ALDH1A1 PCDH7 IGSF3	2.36e-08	189	156	9	87323e86a5b5d159920a07e6bd7ef5e3438cd085
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAN HLA-DOB HLA-DPB1 INPP5F SACS IGHA2 CLEC2D TNFRSF13B EIF3B	3.09e-08	195	156	9	a4d36654b968acb1aea252ac203683939461f1d1
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAN HLA-DOB HLA-DPB1 INPP5F SACS IGHA2 CLEC2D TNFRSF13B EIF3B	3.09e-08	195	156	9	cd811abd949ef201aef1c8515da5575ab1b1cfea
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAN HLA-DOB HLA-DPB1 INPP5F SACS IGHA2 CLEC2D TNFRSF13B EIF3B	3.23e-08	196	156	9	fd756b247b2d8a291e8e71bec6f1e463d6557536
ToppCell	PBMC-Mild-cDC_3\|Mild / Compartment, Disease Groups and Clusters	HLA-DOB HLA-DPB1 GRB7 FAM170B IL1RL1 PCDH7 ZNF548 CNN1	9.04e-08	158	156	8	5fefab4831687cd8dd45f5cc84f681398069c3be
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 LAMB1 ARL4D FAT2 EGFR ALDH1A1 MPZL2 PCDH7	3.03e-07	185	156	8	e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA2D1 MYLK LAMB1 PHEX SNED1 MFAP5 ALDH1A1 NPNT	4.02e-07	192	156	8	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA2D1 MYLK LAMB1 PHEX SNED1 MFAP5 ALDH1A1 NPNT	4.02e-07	192	156	8	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA2D1 MYLK LAMB1 PHEX SNED1 MFAP5 ALDH1A1 NPNT	4.52e-07	195	156	8	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA2D1 MYLK LAMB1 PHEX SNED1 MFAP5 ALDH1A1 NPNT	4.52e-07	195	156	8	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 MXRA5 MYLK LAMB1 ARL4D PHEX PRELP NPNT	5.47e-07	200	156	8	8c62f05c6042f24287a73fbdf80ff4a56f7ff403
ToppCell	Basal_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	FRAS1 EPPK1 ARL4D CNNM1 FAT2 ASXL3 PCDH7	2.01e-06	166	156	7	aea2ae12e4746149ebc6da063ef694381c098f80
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 NUP210L LAMB1 MFAP5 EGFR PRELP IGSF3	2.97e-06	176	156	7	fee4e0f32aaf77294040c7af6c1f503571750d43
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 NUP210L LAMB1 MFAP5 EGFR PRELP IGSF3	2.97e-06	176	156	7	f25251abd4ef9fb077a978f9f9f658af58e4e0d2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK CD248 ARHGEF5 FAM170B ZMYND10 PRELP ADAP2	3.20e-06	178	156	7	7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PDE3A NUP210L MMP28 EXTL1 SLC22A13 KAZALD1 ALDH1A1	3.32e-06	179	156	7	8c9ed247e1c4d655b81ce2f24a9936a7cade718a
ToppCell	facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 MYLK LAMB1 PRELP UBAP1L ALDH1A1 NPNT	3.70e-06	182	156	7	c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 MYLK LAMB1 PRELP UBAP1L ALDH1A1 NPNT	3.70e-06	182	156	7	dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DOB HLA-DPB1 ARL4D MFAP5 IGHA2 CLEC2D TNFRSF13B	4.27e-06	186	156	7	d7d884ff4184636081c350d29f797bd923c6a3b4
ToppCell	normal-na-Lymphocytic_B-B_atypical-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HLA-DOB HLA-DPB1 NRROS ARL4D MFAP5 CLEC2D TNFRSF13B	4.58e-06	188	156	7	e5ab89030783461e9367ab87c353fb5c31911020
ToppCell	normal-na-Lymphocytic_B-B_atypical\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HLA-DOB HLA-DPB1 NRROS ARL4D MFAP5 CLEC2D TNFRSF13B	4.58e-06	188	156	7	13653481d64c7a1ad833d738a3ee0bb9def7cec7
ToppCell	CTRL-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	CLIP2 HLA-DOB HLA-DPB1 INPP5F SP110 SNED1 TNFRSF13B	4.74e-06	189	156	7	14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA2D1 MYLK LAMB1 MFAP5 PRELP ALDH1A1 NPNT	4.74e-06	189	156	7	e76dc36a01d8ad7590b3acc4c46abfcb76857448
ToppCell	remission-B_memory\|World / disease stage, cell group and cell class	HLA-DOB HLA-DPB1 FAM110D SP110 MFAP5 IGHA2 TNFRSF13B	4.91e-06	190	156	7	c3f55f752e47b5a71e111367cdbed4a39ab5cb21
ToppCell	droplet-Lung-18m-Mesenchymal\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA2D1 MYLK LAMB1 MFAP5 PRELP ALDH1A1 NPNT	4.91e-06	190	156	7	0b7200897b2c389632c9b1ee37e272b811555dbc
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA2D1 MYLK LAMB1 MFAP5 PRELP ALDH1A1 NPNT	5.08e-06	191	156	7	c715bbdbbf1482aad45a50a16d5232fd35a9a0bb
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA2D1 MYLK LAMB1 MFAP5 PRELP ALDH1A1 NPNT	5.08e-06	191	156	7	243d83cbfcc4996ad087ec6386e559e0b8662004
ToppCell	droplet-Lung-30m-Mesenchymal\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA2D1 MYLK LAMB1 MFAP5 PRELP ALDH1A1 NPNT	5.26e-06	192	156	7	5d5bec238b196f0b3e727fd94f078d6ae524cb01
ToppCell	droplet-Lung-nan-18m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 MYLK LAMB1 MFAP5 PRELP ALDH1A1 NPNT	5.26e-06	192	156	7	df56c3e3bb1aafc1126607f4426554c09c8c40cf
ToppCell	facs-BAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMB1 MFAP5 EGFR PRELP KAZALD1 IGSF3	5.26e-06	192	156	7	0b3161ce3add9f7457f4cfa5749dbb6501e3ad36
ToppCell	facs-BAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMB1 MFAP5 EGFR PRELP KAZALD1 IGSF3	5.26e-06	192	156	7	61c7ec6171c519b2f3e9ce623669162c0c6ba9f5
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A MYLK LAMB1 PHEX SNED1 ALDH1A1 PCDH7	5.26e-06	192	156	7	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	facs-BAT-Fat-24m-Mesenchymal\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 LAMB1 MFAP5 EGFR PRELP KAZALD1 IGSF3	5.26e-06	192	156	7	24d682e3247a73d349e7776b9e564b6b57f4cb13
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA2D1 LAMB1 MFAP5 PRELP ALDH1A1 IGSF3 NPNT	5.26e-06	192	156	7	1b228f0929b505de82a39bf64c837887b0e56701
ToppCell	NS-critical-d_0-4-Lymphoid-NK\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MXRA5 APOBEC3D CD248 BIVM PMVK IL1RL1 MMP1	5.44e-06	193	156	7	1b29525c5936d1b779253b8c20f059fa091c6127
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA2D1 MYLK LAMB1 MFAP5 PRELP ALDH1A1 NPNT	5.44e-06	193	156	7	4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK LAMB1 PHEX PRELP ALDH1A1 ADAP2 NPNT	5.44e-06	193	156	7	027e098ad018e782287f84eee0f77551018f2196
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA2D1 MYLK LAMB1 MFAP5 PRELP ALDH1A1 NPNT	5.44e-06	193	156	7	ff8ceeb3cfd1bef7239df490c19d181091750833
ToppCell	PND28-Mesenchymal-Mesenchymal_structural\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD248 LAMB1 SNED1 MFAP5 PRELP MSLN NPNT	5.44e-06	193	156	7	ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK LAMB1 PHEX PRELP ALDH1A1 ADAP2 NPNT	5.44e-06	193	156	7	c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK LAMB1 MFAP5 PRELP ALDH1A1 ADAP2 NPNT	5.44e-06	193	156	7	abdfb8b1dbdcb424042e21017a9e829fced4457e
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	CACNA2D1 FRAS1 MYLK LAMB1 PHEX SNED1 PCDH7	5.44e-06	193	156	7	acad568621ed677031797b8c2e34dafea798d681
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD248 LAMB1 SNED1 MFAP5 PRELP MSLN NPNT	5.44e-06	193	156	7	30481fb01c7acf85beae10213f038da86bed6777
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A MYLK LAMB1 PHEX SNED1 ASXL3 PCDH7	5.63e-06	194	156	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGEF5 GRB7 ARL4D FAT2 ALDH1A1 MPZL2 MSLN	5.82e-06	195	156	7	24d226f89dd337c22728688e4b40ca082a0e1fe1
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK LAMB1 ARL4D MFAP5 PCDH7 CNN1 NPNT	5.82e-06	195	156	7	6524ee7bdc70bb5955dd6a6f134a8e6d8b5f2b39
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 CD248 LAMB1 SNED1 MFAP5 EGFR PRELP	6.02e-06	196	156	7	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDE3A MXRA5 MYLK CD248 LAMB1 PRELP TNKS1BP1	6.02e-06	196	156	7	44e2df1b61e3819eae7e482bef0a733afe852d67
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDE3A MXRA5 MYLK CD248 LAMB1 PRELP TNKS1BP1	6.02e-06	196	156	7	cb61757646653f89faba503cb5d99e5dd5197b4c
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 CD248 LAMB1 SNED1 MFAP5 EGFR PRELP	6.02e-06	196	156	7	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-myocytic\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK LAMB1 ARL4D MFAP5 PCDH7 CNN1 NPNT	6.02e-06	196	156	7	20dc9b25ecc23b6e6e52bbab8b5a404f3245ca37
ToppCell	368C-Fibroblasts-Fibroblast-G\|368C / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 MYLK LAMB1 PHEX PRELP ALDH1A1 NPNT	6.22e-06	197	156	7	156155c2f0c1a2461e45803da578af18ee221660
ToppCell	Basal_cells\|World / lung cells shred on cell class, cell subclass, sample id	FRAS1 MXRA5 ARL4D FAT2 EGFR MMP1 PCDH7	6.22e-06	197	156	7	24360b660000bdfb999d58fbf4e29585a97e1785
ToppCell	Severe_COVID-19-Epithelial-transitional_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	EPPK1 ALS2CL ZMYND10 IL1RL1 MPZL2 SLC6A14 MSLN	6.22e-06	197	156	7	5ad3cd4c77016e862041baac3076f8cc0f75c417
ToppCell	BAL-Severe-Epithelial-Epithelial-transitional_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	EPPK1 ALS2CL ZMYND10 IL1RL1 MPZL2 SLC6A14 MSLN	6.22e-06	197	156	7	08b371309cd790b171ed76cabc7d910e71cd2835
ToppCell	368C-Fibroblasts-Fibroblast-G-\|368C / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 MYLK LAMB1 PHEX PRELP ALDH1A1 NPNT	6.22e-06	197	156	7	d5d9263451f6c10cb3b9c17740183ca334e24851
ToppCell	PND14-Mesenchymal\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK CD248 LAMB1 MFAP5 KAZALD1 CNN1 NPNT	6.22e-06	197	156	7	9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe
ToppCell	BAL-Severe-Epithelial-Epithelial-transitional_Epi\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	EPPK1 ALS2CL ZMYND10 IL1RL1 MPZL2 SLC6A14 MSLN	6.22e-06	197	156	7	9f49feee38647bbf964974aac96fa75602186b5c
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPPK1 EGFR MMP1 MPZL2 PCDH7 SLC6A14 HDGF	6.43e-06	198	156	7	77517df37dc894c78ef1e2b24dd7ba31f928bdb7
ToppCell	Severe-B_intermediate-10\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HLA-DPB1 HLA-E ARL4D PHEX MFAP5 CLEC2D ADAP2	6.43e-06	198	156	7	dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCC3 FRAS1 FAT2 EGFR ASXL3 PCDH7 IGSF3	6.65e-06	199	156	7	94a7867e800df352731796de8c24cba133c29622
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	PDE3A MYLK ATAD5 WNT8B TECTA ARID5A CNN1	6.65e-06	199	156	7	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	FRAS1 MYLK LAMB1 PHEX PRELP ALDH1A1 NPNT	6.65e-06	199	156	7	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NBPF3 ABCC3 APOBEC3D HLA-DOB INPP5F ZNF589 ADAP2	6.65e-06	199	156	7	3b2bd3caf4d189a1726a737b0121860b265eec04
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 ARL4D FAT2 EGFR ALDH1A1 MPZL2 PCDH7	6.65e-06	199	156	7	ba284f984909504221900bca5ea12ada5b2ffd9f
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 MYLK LAMB1 PHEX PRELP ALDH1A1 NPNT	6.65e-06	199	156	7	212e89d097753790061310373a1fafba773488b6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 MYLK LAMB1 PHEX PRELP ALDH1A1 NPNT	6.65e-06	199	156	7	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	MYLK SLFN5 DNAJC10 MPZL2 PCDH7 CNN1 NPNT	6.65e-06	199	156	7	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	PSB-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ABCC3 MXRA5 LAMB1 ARL4D FAT2 EGFR MPZL2	6.65e-06	199	156	7	2add64c3e4cb6384ec381f34c3f1f77e13e3f27c
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	FRAS1 MYLK LAMB1 PHEX PRELP PCDH7 NPNT	6.87e-06	200	156	7	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FRAS1 MYLK LAMB1 PHEX PRELP PCDH7 NPNT	6.87e-06	200	156	7	a510deaada669e690329183e18df02870bd204b3
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 CD248 LAMB1 ARL4D MFAP5 KAZALD1 PCDH7	6.87e-06	200	156	7	76f3043cb88071256ff661885fe5a82a54f5b733
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FRAS1 MXRA5 CD248 LAMB1 EGFR NPNT CD276	6.87e-06	200	156	7	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 CD248 LAMB1 ARL4D MFAP5 KAZALD1 PCDH7	6.87e-06	200	156	7	64d2941689d7ca8af54f9ba21c5aeabf719084ef
ToppCell	Biopsy_Other_PF-Mesenchymal\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PDE3A MXRA5 MYLK CD248 LAMB1 PRELP CNN1	6.87e-06	200	156	7	d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FRAS1 MYLK LAMB1 PHEX PRELP PCDH7 NPNT	6.87e-06	200	156	7	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATAD5 WDR18 SP110 DHCR7 PKN1 TIMELESS	2.08e-05	159	156	6	e9c51e611ebd427bbe51e3e036c14122c36ea372
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HLA-DOB SP110 TNFRSF13B HAAO IL1RL1 UNC93B1	2.31e-05	162	156	6	59f6a9005c4f22f084c25ea36f3cacce5144a9ae
ToppCell	Basal_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FRAS1 EPPK1 SCGN ARL4D MMP1 PCDH7	2.48e-05	164	156	6	85487a303194f5244956ec1ca2d1758d38117f41
ToppCell	-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MXRA5 CD248 HLA-DOB MFAP5 IGHA2 TNFRSF13B	2.65e-05	166	156	6	bc9323de1373fdc0357e6bb46874f6c4787443a9
ToppCell	facs-Heart-LV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 NUP210L LAMB1 EGFR PRELP IGSF3	2.93e-05	169	156	6	849a8f8509c58d65462a09c84d58b6ecdc8934f5
ToppCell	facs-Trachea-nan-18m-Myeloid\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DOB NRROS TNFRSF13B HAAO UNC93B1 ADAP2	3.13e-05	171	156	6	9d496a6edac9663791cda684188d49895246f6fe
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD248 TECTA OVCH1 SNED1 MFAP5 PRELP	3.23e-05	172	156	6	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HLA-DOB TWF2 NRROS HAAO TIMELESS UNC93B1	3.23e-05	172	156	6	eaba10a4d4eaab42ad2e2da65ebb20b50edaf815
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA2D1 PDE3A MYLK SACS PCDH7 CNN1	3.34e-05	173	156	6	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 SLC28A3 EGFR LRP2 MSLN IGSF3	3.34e-05	173	156	6	e05cddf5bf63cf419343ff229453327519765be8
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 SLC28A3 EGFR LRP2 MSLN IGSF3	3.34e-05	173	156	6	74ad5ed33821b8816c9c8e67c50ee4496ba18e2f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK ING1 MFAP5 IGHA2 PRELP CNN1	3.56e-05	175	156	6	c6c0196875f3b5293083cda6718300806a801941
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK ING1 MFAP5 IGHA2 PRELP CNN1	3.56e-05	175	156	6	82c4d1edaa0d3b82d3ef4676d6f6516104a2656a
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 MXRA5 MYLK LAMB1 PRELP NPNT	3.80e-05	177	156	6	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 ABCA1 SLFN5 FAM170B PRELP ADAP2	3.80e-05	177	156	6	26bad614560609d318bfc9c235a698bca4e1c22c
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 MXRA5 MYLK LAMB1 PRELP NPNT	3.80e-05	177	156	6	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	Severe-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HLA-DPB1 ARL4D PHEX MFAP5 CLEC2D ADAP2	3.92e-05	178	156	6	b7374a97c51239782bed658381a02cb1b3d9bf66
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CETP HLA-E HLA-F SNED1 DCHS1 SLFN11	3.92e-05	178	156	6	375156ba1c7b8592bf733c75f24968161f7cfa09
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 GRB7 SLC28A3 MFAP5 ZMYND10 EGFR	4.30e-05	181	156	6	e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD248 GRB7 SLC28A3 MFAP5 ZMYND10 EGFR	4.30e-05	181	156	6	35eefd874a892eaf21f24fdce89e7ea3b8ee285f
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA2D1 MYLK LAMB1 PRELP CNN1 NPNT	4.30e-05	181	156	6	b116c68393d8836bac080f81a8fcbeb52e0403e7
Computational	Genes in the cancer module 104.	KIF21B ABCA1 CYP2E1 ING1 HLA-DOB SCGN PGC FAT2 PPT2 TNFRSF13B HAAO MPZL2	7.54e-05	353	97	12	MODULE_104
Computational	Genes in the cancer module 181.	KIF21B ABCA1 CYP2E1 ING1 SCGN PGC FAT2 PPT2 TNFRSF13B HAAO MPZL2	9.35e-05	306	97	11	MODULE_181
Computational	Genes in the cancer module 143.	HLA-DOB HLA-E HLA-F	2.41e-04	14	97	3	MODULE_143
Disease	thoracic aortic aneurysm (is_implicated_in)	MYLK MFAP5 MMP1	2.06e-05	11	150	3	DOID:14004 (is_implicated_in)
Disease	C-C motif chemokine 16 measurement	MMP28 SLFN5 SLFN11	2.74e-05	12	150	3	EFO_0008044
Disease	familial hyperlipidemia (biomarker_via_orthology)	ABCA1 CYP2E1 SLC27A1	1.18e-04	19	150	3	DOID:1168 (biomarker_via_orthology)
Disease	occupational asthma (is_implicated_in)	HLA-DPB1 HLA-E	1.53e-04	4	150	2	DOID:0080820 (is_implicated_in)
Disease	tendinitis (biomarker_via_orthology)	MMP1 LRP5L	3.80e-04	6	150	2	DOID:971 (biomarker_via_orthology)
Disease	REM sleep behavior disorder	TMEM175 INPP5F	3.80e-04	6	150	2	EFO_0007462
Disease	thyroid peroxidase antibody measurement	TPO HLA-DOB HLA-DPB1 TRIM60	5.05e-04	72	150	4	EFO_0005666
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-E HLA-F	5.30e-04	7	150	2	DOID:0081267 (implicated_via_orthology)
Disease	fatty liver disease (biomarker_via_orthology)	ABCC3 ABCA1 CYP2E1	6.28e-04	33	150	3	DOID:9452 (biomarker_via_orthology)
Disease	amino acid measurement	CACNA2D1 PRSS55 LAMB1 MMP25 NELL2 ACAD8 ABCB8 LRP2 PKN1 PRKDC MGAM2	7.25e-04	678	150	11	EFO_0005134
Disease	aspartate aminotransferase measurement	KIF21B ARHGEF19 PDE3A ABCA1 HLA-DPB1 CETP PELI2 POLR2M INPP5F GBA3 CNNM1 MOCOS CD276	7.43e-04	904	150	13	EFO_0004736
Disease	Hypercholesterolemia	ABCA1 MYLK CETP	1.03e-03	39	150	3	C0020443
Disease	Human papillomavirus infectious disease (is_marker_for)	EGFR IL1RL1	1.12e-03	10	150	2	DOID:11166 (is_marker_for)
Disease	Familial thoracic aortic aneurysm and aortic dissection	MYLK MFAP5	1.12e-03	10	150	2	cv:C4707243
Disease	interstitial collagenase measurement	MMP25 MMP1	1.37e-03	11	150	2	EFO_0008193
Disease	coronary artery disease (is_implicated_in)	ABCA1 MYLK IL1RL1 MMP1	1.72e-03	100	150	4	DOID:3393 (is_implicated_in)
Disease	Hyperlipoproteinemia Type IIb	ABCA1 CETP	1.93e-03	13	150	2	C1704417
Disease	cortisol measurement, response to corticosteroid, response to synacthen	SCGN GBA3	1.93e-03	13	150	2	EFO_0005843, EFO_0009175, GO_0031960
Disease	severe acute respiratory syndrome, COVID-19	ABCC3 CACNA2D1 MXRA5 ZNF212 ZNF213 POLR2M SLFN5 LRP5L	2.11e-03	447	150	8	EFO_0000694, MONDO_0100096
Disease	Metabolic Bone Disorder	DHCR7 LRP2	2.24e-03	14	150	2	C0005944
Disease	membranous glomerulonephritis (biomarker_via_orthology)	ABCA1 LRP2	2.24e-03	14	150	2	DOID:10976 (biomarker_via_orthology)
Disease	Osteopenia	DHCR7 LRP2	2.58e-03	15	150	2	C0029453
Disease	level of Phosphatidylcholine (16:0_16:0) in blood serum	CETP PPT2	2.58e-03	15	150	2	OBA_2045067
Disease	Hyperlipoproteinemia Type IIa	ABCA1 CETP	2.94e-03	16	150	2	C0745103
Disease	idiopathic scoliosis (implicated_via_orthology)	MBTPS1 ZMYND10	2.94e-03	16	150	2	DOID:0060250 (implicated_via_orthology)
Disease	phosphorus measurement	NBPF3 PHEX	2.94e-03	16	150	2	EFO_0004861
Disease	Carcinoma, Granular Cell	CYP2E1 GRB7 EGFR MSLN	2.96e-03	116	150	4	C0205644
Disease	Adenocarcinoma, Tubular	CYP2E1 GRB7 EGFR MSLN	2.96e-03	116	150	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	CYP2E1 GRB7 EGFR MSLN	2.96e-03	116	150	4	C0205642
Disease	Carcinoma, Cribriform	CYP2E1 GRB7 EGFR MSLN	2.96e-03	116	150	4	C0205643
Disease	Adenocarcinoma, Basal Cell	CYP2E1 GRB7 EGFR MSLN	2.96e-03	116	150	4	C0205641
Disease	Adenocarcinoma	CYP2E1 GRB7 EGFR MSLN	2.96e-03	116	150	4	C0001418
Disease	Colorectal Carcinoma	ABCC3 ABCA1 CD248 WNT8B EGFR SACS TENM1 DCHS1 LRP2 MMP1	3.24e-03	702	150	10	C0009402
Disease	Atherosclerosis	ABCA1 CETP MMP1	3.40e-03	59	150	3	C0004153
Disease	Atherogenesis	ABCA1 CETP MMP1	3.40e-03	59	150	3	C1563937
Disease	Uterine leiomyoma, estrogen-receptor positive breast cancer	ATAD5 ADAP2	3.72e-03	18	150	2	EFO_1000649, HP_0000131
Disease	Hypercholesterolemia, Familial	ABCA1 CETP	3.72e-03	18	150	2	C0020445
Disease	HDL cholesterol change measurement, physical activity	ABCA1 CETP MRM1	3.91e-03	62	150	3	EFO_0003940, EFO_0007805
Disease	white matter microstructure measurement	CACNA2D1 EPPK1 POLR2M SCGN EGFR LRP2 SUZ12	3.91e-03	390	150	7	EFO_0005674
Disease	chronic obstructive pulmonary disease (is_implicated_in)	CYP2E1 HLA-DPB1 MMP1	4.09e-03	63	150	3	DOID:3083 (is_implicated_in)
Disease	response to methotrexate, neurotoxicity	PKN1 KAZALD1	4.15e-03	19	150	2	EFO_0011057, GO_0031427
Disease	Malignant Neoplasms	DNAJC10 EGFR SUZ12 MSLN	4.20e-03	128	150	4	C0006826
Disease	Prostatic Neoplasms	MBTPS1 CYP2E1 ARHGEF5 GRB7 DNAJC10 EGFR LRP2 PRKDC CD276	4.38e-03	616	150	9	C0033578
Disease	Malignant neoplasm of prostate	MBTPS1 CYP2E1 ARHGEF5 GRB7 DNAJC10 EGFR LRP2 PRKDC CD276	4.38e-03	616	150	9	C0376358
Disease	Alcohol abuse	CYP2E1 EGFR ALDH1A1	4.86e-03	67	150	3	C0085762
Disease	Infiltrating duct carcinoma of female breast	SMG1 PKN1	5.06e-03	21	150	2	C3165106
Disease	esophagus adenocarcinoma (is_implicated_in)	GRB7 MMP1	5.06e-03	21	150	2	DOID:4914 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
RQLGVGAFPVESRWQ	ALS2CL	586	Q60I27
QFWIRSGGGVLEERP	ATAD5	1401	Q96QE3
SVKEPQLVWGGDANR	ARID5A	381	Q03989
SIGEWFGPNTVAQVL	ATG4A	141	Q8WYN0
LQGEREPGWIKQLFT	CETP	171	P11597
NEFGTIIDWAPRGQF	ERVK-18	146	O42043
NEFGTIIDWTPQGQF	ERVK-9	256	Q9UKH3
WSPQGQFVVLAGLRS	EIF3B	616	P55884
SNLLWDTGVFRGPVL	APOBEC3D	46	Q96AK3
TFQVWDVGGQEKLRP	ARL4D	71	P49703
VGWNSQPTRAVIFED	ACAD8	236	Q9UKU7
GVRAWVKENRGSFQP	HAAO	6	P46952
VRLSDGERGWFPVQQ	ARHGEF5	1551	Q12774
GERGWFPVQQVEFIS	ARHGEF5	1556	Q12774
LQRPLRGFTWTTGDQ	CD248	96	Q9HCU0
GIGVQWDNLFESPVE	ABCA1	801	O95477
GENRFVSPLSWDLVG	ABCA1	1836	O95477
RWSGSGFINFQEVPV	ADGRV1	3436	Q8WXG9
PGSIQVRWFLNGQEE	HLA-DPB1	151	P04440
GLWNFPFGTIRQESQ	BIVM	426	Q86UB2
WADKIQGRTIPIDGN	ALDH1A1	136	P00352
TQFAPGQWAGVVLDD	CLIP2	101	Q9UDT6
EAEVFWQDGQGVPLT	CD276	391	Q5ZPR3
GRPGIVAWTLINLSF	DHCR7	241	Q9UBM7
AQGWKQRLAEGEFTP	ASXL3	316	Q9C0F0
GETISLPGNREGFLW	ADAP2	126	Q9NPF8
LQRPFGQRVESIGQW	ANO8	791	Q9HCE9
RGPIKFNVWDTAGQE	RAN	56	P62826
DRGIIFNNGPTWKDI	CYP2E1	111	P05181
LVETRPAGDGTFQKW	HLA-F	251	P30511
WEPSFLKQVEGIRQG	ABCC3	506	O15438
TFSLWQDIPDVRGSG	ARHGEF19	351	Q8IW93
EVWSTQQGPRVGAFN	RAB3GAP2	476	Q9H2M9
SGPQFWVFQDRQLEG	MMP25	386	Q9NPA2
SIISGNWGRVFQLEP	DCHS1	2521	Q96JQ0
LVETRPAGDGTFQKW	HLA-E	251	P13747
AWFLEGTPVRRQEGS	MYLK	446	Q15746
FTEDVGQLPGLTIWQ	FLII	491	Q13045
DDGTPRIVTNLGLQW	FRAS1	2436	Q86XX4
RGGPQRFEVTGWLQI	KAZALD1	226	Q96I82
GWLQIQAVRPSDEGT	KAZALD1	236	Q96I82
GLSEEQLQEPITGWR	LPCAT4	71	Q643R3
TDLPLGTTFWLGQRN	NELL2	181	Q99435
GGANIPALNELLSVW	MBTPS1	751	Q14703
LGQEFSIRWNLPVSD	MGAM2	896	Q2M2H8
FDGRWPRQIVSSIGL	NPNT	21	Q6UXI9
VTQVLGRSPVDFWGA	ENTPD8	146	Q5MY95
ELGLELVFVWNRDPG	ASPDH	31	A6ND91
EFSQILWIGGRNPGE	DDX55	111	Q8NHQ9
LWIGGRNPGEDVERF	DDX55	116	Q8NHQ9
PLGQFGISQVGDEWR	FAT2	2951	Q9NYQ8
AGLEARWTALQEVPG	DLAT	16	P10515
VIGPSQSWVDLFEGQ	PCDH7	116	O60245
PEGWLRLSLNNGSIT	PGAM5	246	Q96HS1
TWNFPIFDLVENIGR	PDE3A	691	Q14432
NIDVWLGGLAENFLP	TPO	631	P07202
WTVTVQELGPFRGIT	CSKMT	216	A8MUP2
SGNAVRIWELSRFQP	KIF21B	1431	O75037
GFSEGLWEIENNPTV	HDGF	81	P51858
VGWSVDFSRPQLGED	HNRNPUL2	316	Q1KMD3
PTDSLQGIILTGWQR	HEXD	286	Q8WVB3
QWLFRELPSQLSGEG	MRS2	161	Q9HD23
RNSGWVFENPSIGVL	LCN6	91	P62502
ELRVLVNASLGWPNG	LRP5L	111	A4QPB2
GSRFWIQDKGPIVES	DPP3	296	Q9NY33
IQDRIPSWTGAGFVR	LAMB1	576	P07942
VTWNFRPLDGGPEQF	MPZL2	61	O60487
GLFNELLENGISVWP	POLG2	401	Q9UHN1
AAFEVTRWPVGNQGL	MOCOS	596	Q96EN8
FSLGWVQPSRTLAGE	MSLN	26	Q13421
NILVFEDLGWPTGLS	LRP2	4221	P98164
SVEVFWPGTIQREGS	FAM170B	31	A6NMN3
EVQAAWPVGGDSRFV	GRB7	166	Q14451
WIPLGVNSQRGDDVT	MFAP5	21	Q13361
GRESLRPLWEQVQGF	PPT2	76	Q9UMR5
TVQGFQWTLRGPDVE	NBPF3	6	Q9H094
ITGFLLIQAWPENRT	EGFR	401	P00533
WQLNGTKITDFGEPR	IL1RL1	251	Q01638
VVSSGRDPQLQGIWF	CD101	306	Q93033
RDPQLQGIWFFNGTE	CD101	311	Q93033
TAGRPQGRFSVIWQL	IGSF3	436	O75054
WQFLSGVTPLNEGVA	CBLIF	386	P27352
TGPIRNGDWTFQTVV	HLA-DOB	171	P13765
QLPSENREGKVLWTG	CENPL	146	Q8N0S6
PAVWQGGETEALARL	CRY2	226	Q49AN0
FDLPQTLEDQGGWLS	GBA3	121	Q9H227
NEFGTIIDWAPRGQF	ERVK-24	146	P61566
VEAPGETFAQRVSWG	POLR2M	66	Q6EEV4
NEFGTIIDWAPRGQF	ERVK-7	146	P61567
NREEDPSLLWQVFGS	CACNA2D1	196	P54289
GEVLLIPQNGFWTLE	BTN2A1	411	Q7KYR7
NEFGTIIDWAPRGQF	ERVK-21	256	P61565
NEFGTIIDWAPRGQF	ERVK-5	146	Q9HDB8
NVTTGSLGEPQWLRV	CLPB	36	Q9H078
GFSPKDVLVRWLQGS	IGHA2	241	P01877
RIWGLGFLPQVSTDL	DNAJC10	661	Q8IXB1
QSPRQGLLQRWEVSG	C1orf127	71	Q8N9H9
LRWVQENIAPFGGDL	CES3	206	Q6UWW8
GFRNWRLLQITGTAP	SLC22A13	246	Q9Y226
EPTLGRLDAAGFWQV	SCGN	6	O76038
QSTGERDGRPLWQKV	INPP5F	191	Q9Y2H2
ETGFPVSEQRLWRGG	SACS	41	Q9NZJ4
ETEQAGVLNWFRVPL	MFSD5	371	Q6N075
WGVLNGSLAPLQDVA	NRROS	496	Q86YC3
FTVQPGNRWSLEVGQ	NUP210L	361	Q5VU65
LDPSWLRGQVVGFIS	ABCB8	541	Q9NUT2
FQWVSQLPVSGVLDR	MMP28	66	Q9H239
GNRLTVLAWVAFQPG	NYX	311	Q9GZU5
AGPVVTDNGNFILDW	RPIA	246	P49247
DVAQFVLTEGNPRWE	MMP1	96	P03956
VRQGEKFLQPLTGWE	PLEKHG4	506	Q58EX7
IVLGPNLLWARNEGT	ARHGAP17	401	Q68EM7
RVDLNVFGSLGLQPW	ING1	51	Q9UK53
LWLVLDGIQDPRNFG	MRM1	146	Q6IN84
FLWERPTLLVLGNEG	MRM1	246	Q6IN84
FSPQWLSRRIAGGEE	OVCH1	566	Q7RTY7
RGGFTEESQPGVWRE	PELI2	196	Q9HAT8
RSGLIQWVDGATPLF	SMG1	2201	Q96Q15
GQFQGRPVSVWDVLF	EPPK1	3181	P58107
RGQFQGRPVSVWDVL	EPPK1	4781	P58107
LEVFPEAEWSQGVQG	SLFN11	761	Q7Z7L1
HLFGLTWQLQPVEGE	TENM1	341	Q9UKZ4
ELPDGQVITIGNEWF	POTEI	941	P0CG38
ELPVESFQNATGLRW	PRELP	116	P51888
GQEWINLRDGPITIS	RNF216	21	Q9NWF9
EGSIFQVDLFTWPGQ	WDR18	236	Q9BV38
GPNAWDQSFTLELER	PKN1	411	Q16512
TDPGFIAFDWLGRQV	SLC28A3	246	Q9HAS3
WLTPNEFEVEGKGRN	SP110	496	Q9HB58
QSRQQRGWVFTPGVD	PMVK	136	Q15126
VEVLGAERFSPQSWG	FAM110D	176	Q8TAY7
QGSRPEGRFSALIWV	EXTL1	411	Q92935
FWRLVDSAEIQPIGN	SCMH1	101	Q96GD3
TTTNVGVPGRWAFRI	SNED1	241	Q8TER0
INGTEWTRQFPILGA	CLEC2D	146	Q9UHP7
EWIEGVTGRRIGNNF	CNN1	36	P51911
ENGTGDWAPRLVFIE	CNNM1	96	Q9NRU3
PATFVGSRQWIGSIE	UFSP2	341	Q9NUQ7
QALGIPIGDWRTQTG	TECTA	576	O75443
SAREVWPEGDVFGSQ	TIMELESS	621	Q9UNS1
TQTCWLQLPEFREVG	WNT8B	191	Q93098
EIDLRSVGWGNIFQL	UNC93B1	316	Q9H1C4
LPTGIEGNWGRLLEQ	ZBED2	131	Q9BTP6
QAETLQPSVWFGGRE	TMEM175	401	Q9BSA9
AEGLWEQGFLRTPEQ	ZSCAN32	291	Q9NX65
NGQPLWILGDVFLRS	PGC	356	P20142
AVGNGLRPAIWEEFT	SLC27A1	361	Q6PCB7
QLGGAPNRWEVLSAT	SP3	101	Q02447
QGPTLQFTLRWTGET	SUZ12	351	Q15022
FSREEWGLLGPTQRT	ZNF274	296	Q96GC6
WVGEFSLSVGPQREA	TNKS1BP1	1086	Q9C0C2
ESNIGPEGVWSERKF	PHEX	171	P78562
LLRNWQDQPSVLGGF	TRIM60	371	Q495X7
QEGSLSARWPVAGQI	PRKDC	2621	P78527
VGEFPWQVSIQARSE	PRSS55	76	Q6UWB4
ERTALFWVEAAGQGP	UBAP1L	46	F5GYI3
DQEERFPQGLWTGVA	TNFRSF13B	16	O14836
EQFLTVLPGEIQGWV	ZNF213	91	O14771
IGENLSRGDDWIPSF	ZNF548	126	Q8NEK5
QAFLSPEQTELWGGQ	ZNF212	241	Q9UDV6
SPWSRREGGKLQQFE	ZMYND10	226	O75800
RVEGGVRPLFWSTNE	ZNF589	146	Q86UQ0
LGQFASLGPVSVWRI	SLC6A14	96	Q9UN76
FVNRGGLPVDEATWE	VASH1	61	Q7L8A9
KFITQTARDGPGVLW	SLFN5	666	Q08AF3
QLVLGASQEPVGRWD	TWF2	36	Q6IBS0
QRLQWEVSFELGTPG	VWA5B1	821	Q5TIE3
WAVQGRPFEVRTGTL	SLC8A2	841	Q9UPR5
WVLGDGTQIRPSQFL	MXRA5	2081	Q9NR99
NFVGDWPVDKTIGQR	N4BP2	786	Q86UW6